Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
DiaMedica Therapeutics Inc
DMAC
Healthcare
Biotechnology
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. Its lead candidate DM199 (rinvecalinase alfa) is the first pharmaceutically active recombinant (synthetic) form of the human tissue kallikrein-1 (KLK1) protein to be clinically studied in...
patients. KLK1 is an established therapeutic modality in Asia, with human urinary KLK1, for the treatment of acute ischemic stroke and cardio renal disease, including hypertension. It has also produced a potential novel treatment for severe inflammatory diseases, DM300, which is in the early preclinical stage of development. KLK1 is a serine protease, or protein, produced primarily in the kidneys, pancreas and salivary glands. KLK1 plays a critical role in the regulation of local blood flow and vasodilation in the body, as well as an important role in reducing inflammation and oxidative stress.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:DMAC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2)
•••
Pugsrock2
X
View Profile
View Bullboard History
Post by
Pugsrock2
on Oct 08, 2019 3:28pm
Looking good....
FOR NOTHING
(9)
•••
joelou
X
View Profile
View Bullboard History
Comment by
joelou
on Sep 26, 2019 7:43pm
RE:What is happening?
That’s easy! - small cap biotech with no results. Where’s the Ischemic results? Kidney? Nothing anytime soon. - May need to do another raise - Chinese trial a no go All this
...more
(0)
•••
WesCoast
X
View Profile
View Bullboard History
Post by
WesCoast
on Sep 26, 2019 1:25pm
What is happening?
Does anyone have any info on the stock tanking this week? It’s doesnt look good
(71)
•••
StockscoutX
X
View Profile
View Bullboard History
Comment by
StockscoutX
on Sep 06, 2019 11:55am
RE:RE:RE:RE:Great Analysis and pointing out new buying by insiders
Indeed it's very interesting but where will it all lead? So far the market is showing no interest in the stock and the trading volume seem to have evaporated. The only thing that would propel
...more
(99)
•••
RockLobster1
X
View Profile
View Bullboard History
Comment by
RockLobster1
on Sep 01, 2019 9:30am
RE:RE:RE:Great Analysis and pointing out new buying by insiders
that one formatted great... thanks for posting it, very interesting.
(1499)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Aug 31, 2019 2:43pm
RE:RE:Great Analysis and pointing out new buying by insiders
I'll try it once more: Great Analysis and pointing out new buying by insiders An unscrupulous Chinese attempt to extort DiaMedica (DMAC) (*see
...more
(1499)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Aug 31, 2019 2:22pm
RE:Great Analysis and pointing out new buying by insiders
See if this formats any better: (it looks alright before I hit the "post" button) Great Analysis and pointing out new buying by insiders An
...more
(9)
•••
Winnipeg40
X
View Profile
View Bullboard History
Post by
Winnipeg40
on Aug 31, 2019 10:28am
Great Analysis and pointing out new buying by insiders
An unscrupulous Chinese attempt to extort DiaMedica (DMAC) (*see disclosure below) into giving up control of its trade secrets caused its stock price to plunge. In a show of confidence, company execs
...more
(9)
•••
Winnipeg40
X
View Profile
View Bullboard History
Comment by
Winnipeg40
on Aug 28, 2019 8:27pm
RE:RE:RE:The deal that ended with China.
You have it backward...their largest shareholder is a subsidiary of the pharmaceutical co. This is a typcial Chinese game....Trump has it right regarding Chinese IP theft.
(1)
•••
TrueNorth911
X
View Profile
View Bullboard History
Comment by
TrueNorth911
on Aug 28, 2019 5:55pm
RE:RE:The deal that ended with China.
hmmmm.... but the FO went to their largest shareholder.... who owns the chinese company trying to steal the IP. Something stinks in beantown.
(71)
•••
StockscoutX
X
View Profile
View Bullboard History
Comment by
StockscoutX
on Aug 28, 2019 11:30am
RE:RE:The deal that ended with China.
Hi Winnipeg40. Thanks for the information. I wasn't able to be at the conference to get the information. Now it more clear. Cheers!
(9)
•••
Winnipeg40
X
View Profile
View Bullboard History
Comment by
Winnipeg40
on Aug 28, 2019 9:19am
RE:The deal that ended with China.
The conference call was crystal clear. They wanted to change the deal to include the IP, so Pauls told them to take a hike and kept their $500K...end of story. Typical Chinese...switch and bait
...more
(71)
•••
StockscoutX
X
View Profile
View Bullboard History
Post by
StockscoutX
on Aug 27, 2019 2:19pm
The deal that ended with China.
What were the probable causes? Does anyone know? DiaMedica Therepeutics didn't give any details as to why. I couldn't find anything in the public domain about the reasons. There could be only
...more
(2)
•••
Pugsrock2
X
View Profile
View Bullboard History
Post by
Pugsrock2
on Aug 14, 2019 8:59pm
Back to 2015
(1499)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Aug 14, 2019 7:12pm
RE:RE:No chinese money
Yeah, check out Zecotek since they relocated to China last year. V.ZMS
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This Small-Cap Gold Stock Jumped Almost 50% on Friday
Nanalysis Scientific Corp. Announces First Quarter 2024 Results